BSX vs MTX · P/E 20, rev $10.65B vs P/E 15, rev $1.10B
Boston Scientific Corp (BSX) versus Minerals Technologies Inc (MTX) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Minerals Technologies Inc (MTX) is a specialty chemicals company listed on NYSE.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported MTX revenue for 2026-07-05 was $1.10B. Net income was -$147.4M. MTX currently screens at market cap $2.39B and trailing P/E 15.1.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. MTX currently screens at market cap $2.39B and trailing P/E 15.1.
Not investment advice. Open the BSX and MTX stock pages for the full models.
Not investment advice.